
Fig. 3. RNase protection assay of ETA and ETB mRNAs expressed in embryonic chick hearts at various stages during development. (A) Autoradiogram of 32P-labelled probes protected by ETA, VMHC1 and GAPDH mRNAs from whole heart (wh), atrium (at), right ventricle (rv) and left ventricle (lv). VMHC1 and GAPDH served as internal controls to normalize the data of ET receptor mRNAs. Developmental stages are indicated by days of incubation. (B) Quantitation of ETA mRNA levels expressed in ventricular and atrial chambers during heart development. The data from three different experiments were normalized and averaged. (C) Autoradiograms of RNase protection assay for ETA and ETB mRNAs. (D) Quantitation of changes in expression levels of ETA and ETB mRNAs in atrial and ventricular chambers during Purkinje fiber differentiation. The data are presented as the ratio of ETB mRNA to ETA mRNA. (E) Left ventricle-dominant expression of ETB in embryonic hearts. Bars indicate standard deviation.